Interius is a clinical stage biotechnology company, engineering targeted, programmable vectors for the precision delivery of genetic medicines to treat an array of challenging diseases.
Investor insights
Funding rounds participated in
$51M sweet spot round size
Investor type
Privately Held
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Funding rounds raised
Total raised
$51M
from investors over 1 rounds
I
Interius BioTherapeutics raised $51M on July 3, 2024